ОбзорГрафикНовостиTraderScreen

BNP Paribas Aktienanleihe ZAL 27..../  DE000PE0LZQ6  /

EUWAX
20.05.2024  10:19:00 Изменение-2.92 Бид13:50:02 Предложение13:50:02 Базовый актив Цена исполнения Дата истечения Тип опциона
59.21EUR -4.70% 60.32
Величина цены спроса: 100,000		 60.42
Величина цены предложения: 100,000		 ZALANDO SE 42.00 - 27.06.2024 Call
GlobeNewswire 14:05 Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
GlobeNewswire 14:05 NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Diseas...
GlobeNewswire 14:01 Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Pric...
GlobeNewswire 14:01 BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation ...
GlobeNewswire 14:01 Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for it...
GlobeNewswire 14:00 Seacoast Bank Welcomes Tony Coley as Regional President, South Florida
GlobeNewswire 14:00 Genius Group Announces Exercise of Warrants for $3.8 Million Gross Proceeds
GlobeNewswire 14:00 Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Perio...
GlobeNewswire 14:00 InnovAge Welcomes John Koehn as Senior Vice President of External Affairs
GlobeNewswire 14:00 Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
GlobeNewswire 14:00 Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Tes...
GlobeNewswire 14:00 Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO ...
GlobeNewswire 14:00 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire 14:00 Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile...
GlobeNewswire 14:00 PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
GlobeNewswire 14:00 PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foo...
GlobeNewswire 14:00 Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 14:00 “Breaking Points” Podcast Launches on Rumble
GlobeNewswire 14:00 NV5 Strengthens Subscription-Based Services with Acquisition of myBIMteam
GlobeNewswire 14:00 Sow Good to Ring the Nasdaq Opening Bell Today, May 20, 2024
GlobeNewswire 14:00 CervoMed to Appoint William Elder as Chief Financial Officer
GlobeNewswire 14:00 RYVYL Extends its Obligation to Repay Convertible Note to April 2026
GlobeNewswire 14:00 Zehnder’s of Frankenmuth Announces Future Plans
GlobeNewswire 14:00 Volta Medical presents results from the first transatlantic randomized controlled trial comparing AI...
GlobeNewswire 14:00 GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...